Redwood City, CA, United States of America

Anne M Merchant


Average Co-Inventor Count = 4.0

ph-index = 5

Forward Citations = 413(Granted Patents)


Company Filing History:


Years Active: 2007-2016

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Anne M Merchant

Introduction

Anne M Merchant is a prominent inventor based in Redwood City, CA (US). She has made significant contributions to the field of biotechnology, particularly in the development of multispecific antibodies. With a total of 5 patents to her name, her work has advanced the understanding and application of antibody technology.

Latest Patents

One of her latest patents is titled "Method for making multispecific antibodies having heteromultimeric and common components." This invention relates to a method of preparing heteromultimeric polypeptides, including bispecific antibodies, bispecific immunoadhesins, and antibody-immunoadhesin chimeras. The method provides a multispecific antibody that has a common light chain associated with each heteromeric polypeptide possessing an antibody binding domain. Furthermore, it introduces specific interactions at the interfaces of polypeptides to promote heteromultimer formation while hindering homomultimer formation. This innovative approach enhances the formation of desired heteromultimers relative to undesired variants.

Career Highlights

Throughout her career, Anne has worked with notable companies such as Genentech, Inc. and Genetech, Inc. Her expertise in antibody technology has positioned her as a key figure in the biotechnology sector.

Collaborations

Anne has collaborated with esteemed colleagues, including W Robert Arathoon and Paul J Carter. These partnerships have further enriched her research and development efforts in the field.

Conclusion

Anne M Merchant's contributions to the field of biotechnology, particularly in the development of multispecific antibodies, highlight her innovative spirit and dedication to advancing medical science. Her work continues to influence the landscape of antibody technology and its applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…